Vardenafil (Levitra)

What is VARDENAFIL (LEVITRA)?

VARDENAFIL (LEVITRA) is a modern medication from the group of phosphodiesterase type 5 inhibitors, which is used to correct erectile dysfunction in men. The drug helps to restore the natural physiological response to sexual stimulation by improving blood supply to the corpora cavernosa of the penis. The pharmacological effect develops after oral administration and persists for several hours, which allows planning intimate intimacy without unnecessary tension. The release form is usually represented by tablets for oral use with different dosages of the active substance. The manufacturer ensures quality standards that meet the requirements of pre-registration control of medicines.

The mechanism of action of VARDENAFIL (LEVITRA) is based on blocking the PDE-5 enzyme, which increases the level of cyclic guanosine monophosphate in the smooth muscles of blood vessels. This leads to relaxation of the vascular wall and increased blood flow to the tissues of the penis during arousal. It is important to understand that the drug does not cause an erection automatically: sexual stimulation is required, otherwise the clinical effect will not develop. This approach makes therapy more physiological compared to agents that act independently of arousal. Before starting the course, a doctor's consultation is mandatory, as the body's reaction is always individual.

VARDENAFIL (LEVITRA) belongs to prescription drugs and is not intended to increase potency in healthy men without diagnosed disorders. It is used in complex tactics of managing patients with organic, psychogenic, or mixed forms of erectile dysfunction. Clinical studies confirm the effectiveness and predictability of action, provided that the recommended regimen is observed. Storage and transportation must comply with the instructions so as not to lose the stability of the active substance. Self-medication without examination can mask serious cardiovascular diseases, so medical supervision remains mandatory.

Why is VARDENAFIL (LEVITRA) prescribed?

The main indication for the use of VARDENAFIL (LEVITRA) is erectile dysfunction — the persistent inability to achieve or maintain an erection sufficient for sexual intercourse. The drug is prescribed to men whose disorders are associated with vascular changes, neurological factors, hormonal shifts, or psycho-emotional stress. The doctor assesses the severity of symptoms, concomitant diseases, and possible risks before choosing a dose. Therapy is aimed not only at restoring erection, but also at improving the quality of life of the couple. The decision on prescription is made individually after gathering history and, if necessary, additional examinations.

VARDENAFIL (LEVITRA) may be recommended for patients with diabetes mellitus, in whom erectile disorders occur more frequently due to damage to small vessels and nerve fibers. The agent is also considered for erectile dysfunction against the background of arterial hypertension, atherosclerosis, or after certain surgical interventions in the pelvic area, if there are no absolute contraindications. It is important that the underlying disease is compensated, and the cardiovascular risk is assessed by a cardiologist. The drug does not cure the cause of dysfunction, but helps to temporarily restore the mechanism of erection. A comprehensive approach often includes lifestyle correction, glucose control, and smoking cessation.

Sometimes VARDENAFIL (LEVITRA) is used in schemes agreed with a specialist when it is necessary to check the vascular reserve or support sexual function during rehabilitation. Indications are always determined by a doctor, and not by the patient independently based on promotional materials. The drug is not intended for women and is not used for the treatment of infertility or premature ejaculation as the main problem. Any extension of indications outside the instructions is considered off-label and requires separate justification. Before taking, it is necessary to inform the doctor about all chronic diseases and medicines that are already being taken.

Composition and active components of VARDENAFIL (LEVITRA)

The active substance of VARDENAFIL (LEVITRA) is vardenafil — a selective inhibitor of phosphodiesterase type 5. It is this molecule that ensures the relaxation of the smooth muscles of the vessels of the penis and increased blood filling during sexual stimulation. After absorption in the digestive tract, the substance reaches the systemic circulation and exerts its effect mainly in tissues where PDE-5 is most actively represented. Selectivity reduces the effect on other isoforms of the enzyme, which is important for the safety profile. The dosage of the active substance in the tablet is selected to ensure a balance between efficacy and tolerability.

In addition to vardenafil, the composition includes auxiliary components: fillers, binders, disintegrants, and a film coating, which ensure tablet stability, ease of swallowing, and controlled release. These ingredients do not have an independent pharmacological effect, but affect the rate of dissolution and bioavailability. Patients with known hypersensitivity to any component should carefully read the full composition in the instructions. The mechanism of action of vardenafil does not replace the natural mediators of arousal, but only enhances their local vascular effect. The individual reaction of the body to the composition may differ, so the first intake should preferably be carried out under the supervision of a specialist.

The pharmacokinetics of VARDENAFIL (LEVITRA) is characterized by a relatively rapid onset of action and a duration sufficient for most clinical situations. Metabolism occurs mainly in the liver with the participation of the cytochrome enzyme system, which explains the importance of considering drug interactions. Excretion of metabolites is carried out with bile and partially by the kidneys. Understanding the composition helps the patient and the doctor to predict the response to therapy and avoid incompatible combinations. Any changes in the composition of different series are recorded by the manufacturer in accordance with the registration dossier.

Dosage of VARDENAFIL (LEVITRA)

The recommended starting dose of VARDENAFIL (LEVITRA) for most adult men is usually the average value from the line of available dosages and is selected by the doctor individually. The tablet is taken as needed, approximately one hour before expected sexual activity, but no more than once a day. The duration of the course is not fixed: the drug is used episodically or according to a scheme agreed with a specialist, depending on the frequency of sexual contact and the body's response. Dose adjustment is possible both upwards and downwards in case of insufficient effect or the appearance of adverse reactions. Elderly patients and individuals with impaired liver function often require a lower starting dose.

The maximum daily dose should not exceed the value specified in the official instructions, even if the effect seems insufficient. Independent increase in the number of tablets increases the risk of arterial hypotension, headache, and other undesirable phenomena. In mild or moderate renal impairment, adjustment may not be required, but the decision remains with the doctor after evaluating the tests. It is important not to combine several drugs from the group of PDE-5 inhibitors in one day. Efficacy and safety depend on strict adherence to the prescribed regimen and regular monitoring of well-being.

If after several attempts at the recommended dose the expected result is not achieved, you should not immediately increase the amount of the drug — a repeat consultation is required. The doctor can check the administration technique, the influence of food, concomitant medications, and psychological factors. Sometimes the dosage of VARDENAFIL (LEVITRA) is adjusted after stabilization of blood pressure or compensation for diabetes. Long-term uncontrolled use does not replace the treatment of the underlying diseases that caused erectile dysfunction. Any change in dose is recorded in the medical documentation for further monitoring.

How to take VARDENAFIL (LEVITRA) correctly?

VARDENAFIL (LEVITRA) is taken orally, swallowed with a small amount of clean water, without chewing the tablet. The optimal time is approximately 25–60 minutes before sexual activity so that the active substance has time to be absorbed. Fatty food can delay the onset of action, so it is advisable to avoid heavy meals immediately before taking the drug. Alcohol in large quantities reduces the quality of erection and increases the likelihood of dizziness, so it is better to limit it. The drug works only in the presence of sexual stimulation, of which the patient must be informed.

In case of missing a planned intake, the next dose is not doubled: simply take the usual amount before the next intimacy, observing an interval of at least 24 hours. It is not recommended to take the agent "just in case" daily without need, unless the doctor has prescribed another regimen. During therapy, it is worth monitoring blood pressure and paying attention to sudden changes in vision or hearing. Store tablets in their original packaging out of reach of children. Before first use, carefully read the package leaflet and clarify any unclear points with your doctor.

Correct intake of VARDENAFIL (LEVITRA) also includes assessing the readiness of the cardiovascular system for physical activity, which is sexual intercourse. Patients after a recent heart attack, stroke, or with unstable angina first need a consultation with a cardiologist. Do not combine the drug with other potency stimulants without agreement. If an erection lasts more than four hours, seek medical help immediately due to the risk of priapism. The individual reaction of the body may differ, so even with adherence to the instructions, medical support is required.

Side effects of VARDENAFIL (LEVITRA)

The most common side effects of VARDENAFIL (LEVITRA) include headache, facial flushing, nasal congestion, dyspepsia, and mild dizziness. These phenomena are usually associated with vasodilation and pass on their own within a few hours. The intensity depends on the dose, patient sensitivity, and concomitant alcohol consumption. Most men tolerate therapy satisfactorily with a properly selected dosage. The appearance of persistent or aggravated symptoms should be reported to the doctor for possible adjustment of the scheme.

Uncommon reactions include sleep disturbances, increased sensitivity of the eyes to light, back muscle pain, palpitations, and decreased blood pressure. Rare but serious effects may include sudden loss of vision in one eye, sharp deterioration in hearing, allergic rashes, or a prolonged painful erection. In such cases, administration is stopped immediately and emergency help is sought. Patients with anatomical deformation of the penis have a higher risk of complications and require special supervision. Any unusual reaction of the body is a reason for a repeat consultation.

When to contact a doctor is mandatory: in case of chest pain during or after intimacy, severe dizziness with loss of balance, swelling of the face, or difficulty breathing. A specialist evaluation is also needed if side effects recur even at the minimum dose. The doctor may suggest an alternative drug or additional examination of the blood vessels and heart. Independent masking of symptoms with painkillers does not solve the problem. Remember that the safety profile of VARDENAFIL (LEVITRA) has been studied, but individual tolerance is always different.

Contraindications of VARDENAFIL (LEVITRA)

Absolute contraindications to VARDENAFIL (LEVITRA) are the simultaneous use of any nitrates and nitric oxide donors due to the risk of a sharp drop in blood pressure. The drug is not prescribed for hypersensitivity to vardenafil or auxiliary substances, as well as for severe hepatic impairment. It is contraindicated in men for whom sexual activity is not recommended for cardiological reasons: recent myocardial infarction, stroke, unstable angina, uncontrolled arrhythmia. Use together with riociguat is also prohibited. Before starting therapy, the doctor must exclude these conditions.

Relative contraindications include moderate liver function impairment, anatomical deformations of the penis, predisposition to priapism, active peptic ulcer disease, and bleeding. Caution is required in patients with arterial hypotension or vice versa — difficult-to-control hypertension. VARDENAFIL (LEVITRA) is not intended for women, during pregnancy and lactation, as well as for persons under 18 years of age. In elderly patients, therapy is started with lower doses and tolerance is monitored more frequently. The decision on the possibility of taking in complex clinical cases is made only by a specialist.

Special groups require additional examination: men after radical prostatectomy, patients with diabetic neuropathy, and individuals taking alpha-blockers. In such situations, the interval between medications and the starting dose are agreed separately. The drug is not used for the prevention of erectile dysfunction in healthy people. Ignoring contraindications can lead to life-threatening complications. Consultation with a doctor before taking is an obligatory condition for safe use.

Interaction of VARDENAFIL (LEVITRA) with other drugs and alcohol

VARDENAFIL (LEVITRA) has clinically significant interactions with nitrates, amyl nitrite, and other vasodilators — such a combination is strictly prohibited. Strong CYP3A4 inhibitors (some antifungals, macrolides, HIV protease inhibitors) can increase the concentration of vardenafil in the blood, so the dose is reduced or the combination is avoided. Alpha-blockers can enhance the hypotensive effect, especially during the first co-administration. Antiarrhythmic drugs of certain classes also require caution due to the possible effect on the QT interval. The full list of medications that the patient takes constantly must be shown to the doctor before prescription.

Alcohol in moderate doses formally does not cancel the effect of the drug, but significantly worsens the quality of erection, increases dizziness and the load on the heart. Alcohol abuse against the background of VARDENAFIL (LEVITRA) increases the risk of orthostatic hypotension. Regarding driving: in the first hours after administration, dizziness and changes in color perception are possible, so you should get behind the wheel only after assessing your well-being. Working with mechanisms also requires caution until the individual reaction is clarified. A safe combination with other drugs is possible only after a professional assessment of interactions.

Where to buy VARDENAFIL (LEVITRA) in Ukraine

VARDENAFIL (LEVITRA) is available in pharmacy chains of Ukraine by doctor's prescription, and can also be ordered through official pharmacy services with delivery in accordance with current legislation. When choosing a place of purchase, it is important to check the availability of quality certificates and the integrity of the packaging to avoid counterfeit. The drug should be stored in a dry place at the temperature specified in the instructions, away from direct sunlight and out of reach of children. Delivery is carried out in compliance with cold chain or normal conditions depending on the manufacturer's requirements. Before use, always check the expiration date and the appearance of the tablets.

The purchase of VARDENAFIL (LEVITRA) does not replace consultation with a urologist, andrologist, or family doctor. A specialist will help determine the feasibility of therapy, select the dose, and exclude contraindications. The individual reaction of the body to the drug may differ, so even with the same diagnosis, the treatment regimen will be different. Do not use the product from doubtful sources without documents. A responsible attitude to health begins with professional diagnostics and compliance with medical recommendations.